FDA Grants PMTA Authorization to Age-Verified Vape Device — A Milestone for ENDS Regulation
In a significant regulatory development, the U.S. Food and Drug Administration officially issued a marketing authorization order on March 12 (ET), approving the Glas G² Device along with its Blonde Tobacco 50mg/mL pod under the Premarket Tobacco Product Application (PMTA) pathway.
Developed by Glas Inc., the Glas G² becomes the first electronic nicotine delivery system (ENDS) in the United States to receive authorization with device-level age verification technology built directly into the hardware. The FDA simultaneously updated its database, revising the product name from “Glas G Device” to “Glas G² Device.”
A Five-Year Review Under Strict Public Health Standards
The PMTA for this product was originally submitted on July 21, 2021. After nearly five years of scientific review, the FDA concluded that the product meets the “Appropriate for the Protection of Public Health” (APPH) standard.
As part of the evaluation, regulators examined:
- Chemical composition and emissions
- Microbiological stability
- Product consistency over time
The agency confirmed that the device and its tobacco-flavored pod remained stable over an approximate 32-week period, with no significant safety concerns identified.
Built-In Age Verification Sets a New Benchmark
What makes the Glas G² stand out is its integrated age verification system at the hardware level. This feature is designed to restrict access by underage users before the device can even be operated.
The FDA’s authorization also comes with strict marketing and access controls, including:
- Mandatory third-party age and identity verification for online sales
- Digital advertising limited to adults aged 25–54
- Broadcast advertising (TV/radio) must reach at least 85% adult audiences, with strict limits on youth exposure (ages 12–17)
- Ongoing monitoring requirements to prevent underage targeting
This dual approach — combining technology safeguards with regulatory oversight — signals a clear direction for future PMTA submissions.
Flavor Outlook: Tobacco Approved, Menthol Still Pending
At this stage, authorization applies only to the Blonde Tobacco pod. Other reported variants, including menthol and flavored options, have not yet been approved and remain under FDA review.
However, company leadership has expressed optimism. According to Glas executives, the scientific data supporting this application aligns closely with the FDA’s latest draft guidance on flavored ENDS products. Additional submissions covering menthol and other flavors are currently in progress.
Why This Matters for the Vape Industry
This approval is more than a single product milestone — it may reshape the regulatory landscape for vaping in the U.S.:
- Age verification technology could become a standard requirement for future devices
- PMTA success may increasingly depend on youth prevention measures
- The pathway for menthol and flavored products could gradually reopen, depending on regulatory alignment
For manufacturers navigating the PMTA process, the Glas G² case offers a clear signal: compliance is no longer just about the product itself, but also about how effectively it prevents unintended use.